Log In
Print
BCIQ
Print
Print this Print this
 

Kaletra, lopinavir/ritonavir

Also known as: ABT-378/r

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionCombination of the HIV protease inhibitor lopinavir plus ritonavir, which inhibits the cytochrome P450 3A4 (CYP3A4)-mediated metabolism of lopinavir
Molecular Target HIV protease
Mechanism of ActionViral protease inhibitor
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today